Sellas Life Sciences Stock In The News

SLS Stock  USD 1.22  0.02  1.61%   
Our overall analysis of Sellas Life's news coverage and content from conventional and social sources shows investors' bearish mood towards Sellas Life Sciences. The specific impact of Sellas Life news on its stock price will depend on a range of factors, including the nature and significance of the news report and investors' perceptions of Sellas Life's overall financial health and prospects. It also depends on the type and quality of a news publisher.
  
Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using Sellas Life headlines in addition to utilizing other, more conventional financial analysis modules. Check out Sellas Life Backtesting and Sellas Life Hype Analysis.

Sellas Life Today Top News and Investor Outlook

Macroaxis News: globenewswire.com
SELLAS Life Sciences Reaches Target Enrollment ex-China in Phase 3 REGAL Trial of Galinpepimut-S in Acute Myeloid Leukemia
https://www.globenewswire.com/news-release/2023/11/29/2787776/0/en/SELLAS-Life-Sciences-Reaches-Target-Enrollment-ex-China-in-Phase-3-REGAL-Trial-of-Galinpepimut-S-in-Acute-Myeloid-Leukemia.html
 Bullish
Macroaxis News: globenewswire.com
SELLAS Life Sciences Receives Favorable ...
https://www.globenewswire.com/news-release/2023/11/13/2779090/0/en/SELLAS-Life-Sciences-Receives-Favorable-FDA-Type-C-Meeting-Feedback-on-Chemistry-Manufacturing-and-Controls-CMC-Biologics-License-Application-BLA-Filing-Strategy-for-Galinpepimut-S.html
 Neutral
Macroaxis News: globenewswire.com
SELLAS Provides Business Update and Reports Third Quarter 2023 Financial Results
https://www.globenewswire.com/news-release/2023/11/09/2777828/0/en/SELLAS-Provides-Business-Update-and-Reports-Third-Quarter-2023-Financial-Results.html
 Bullish
Macroaxis News: globenewswire.com
SELLAS Life Sciences Presents Positive K...
https://www.globenewswire.com/news-release/2023/11/06/2774155/0/en/SELLAS-Life-Sciences-Presents-Positive-Key-Immunobiological-and-Clinical-Data-from-Phase-1-2-Trial-of-Galinpepimut-S-GPS-in-Combination-with-Keytruda-in-WT1-Platinum-Resistant-Adva.html
 Neutral
Macroaxis News: globenewswire.com
SELLAS Life Sciences Announces $4 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
https://www.globenewswire.com/news-release/2023/10/31/2770147/0/en/SELLAS-Life-Sciences-Announces-4-Million-Registered-Direct-Offering-Priced-At-the-Market-Under-Nasdaq-Rules.html
 Neutral
Macroaxis News: globenewswire.com
SELLAS Life Sciences Receives Fast Track Designation from FDA for SLS009 for Treatment of Relapsed/Refractory Peripheral T-cell Lymphomas
https://www.globenewswire.com/news-release/2023/10/30/2769302/0/en/SELLAS-Life-Sciences-Receives-Fast-Track-Designation-from-FDA-for-SLS009-for-Treatment-of-Relapsed-Refractory-Peripheral-T-cell-Lymphomas.html
 Neutral
Macroaxis News: globenewswire.com
SELLAS Life Sciences to Present Final Da...
https://www.globenewswire.com/news-release/2023/10/17/2761536/0/en/SELLAS-Life-Sciences-to-Present-Final-Data-from-Phase-1-2-Study-of-Galinpepimut-S-in-Combination-with-Keytruda-pembrolizumab-in-Patients-with-WT1-Platinum-Resistant-Advanced-Ovaria.html
 Neutral
Macroaxis News: globenewswire.com
SELLAS Announces Positive Initial Topline Phase 2a Data of SLS009 in Acute Myeloid Leukemia
https://www.globenewswire.com/news-release/2023/10/16/2760681/0/en/SELLAS-Announces-Positive-Initial-Topline-Phase-2a-Data-of-SLS009-in-Acute-Myeloid-Leukemia.html
 Bullish
Macroaxis News: globenewswire.com
SELLAS Life Sciences Provides Update on Phase 3 REGAL Clinical Trial for Galinpepimut-S in Acute Myeloid Leukemia
https://www.globenewswire.com/news-release/2023/10/12/2759651/0/en/SELLAS-Life-Sciences-Provides-Update-on-Phase-3-REGAL-Clinical-Trial-for-Galinpepimut-S-in-Acute-Myeloid-Leukemia.html
 Neutral
Macroaxis News: globenewswire.com
SELLAS Announces First Patient Dosed in Phase Ib/II Trial of SLS009 (GFH009) in Relapsed/Refractory Peripheral T-cell Lymphomas
https://www.globenewswire.com/news-release/2023/10/11/2758352/0/en/SELLAS-Announces-First-Patient-Dosed-in-Phase-Ib-II-Trial-of-SLS009-GFH009-in-Relapsed-Refractory-Peripheral-T-cell-Lymphomas.html
 Neutral

Sellas Life Sciences Past News Timeline

Popular news outlets such as MarketWatch, Bloomberg, or Reuters provide Sellas and other traded companies coverage with news coverage. We help investors stay connected with Sellas headlines for the 22nd of November to make an informed investment decision based on correlating the impacts of news items on Sellas Stock performance. Please note that trading solely based on the Sellas Life Sciences hype is not for everyone as timely availability and quick action are needed to avoid losses.
Sellas Life's linear event process diagram shows some of the filtered current and past headlines as well as many other corporate-specific events such as SEC filings, dividends, and regulatory reporting available to the public. This module can help Sellas Life Sciences investors visualize upcoming and past events in order to time the market based on Sellas Life Sciences noise-free hype analysis.
Sellas Life stock price changes are notoriously difficult to predict based exclusively on its news coverage or social hype. Still, the Sellas earnings-per-share ratio is a good starting point for gauging a company's future prospects. If a firm's EPS rises and meets or even beats consensus forecasts, its shares stand to increase. However, some very sophisticated investors can spot management manipulation of EPS through actions such as buybacks.
Far too much social signal, news, headlines, and media speculation about Sellas Life that are available to investors today. That information is available publicly through Sellas media outlets and privately through word of mouth or via Sellas internal channels. However, regardless of the origin, that massive amount of Sellas data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Sellas Life news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Sellas Life relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Sellas Life's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Sellas Life alpha.

Sellas Largest EPS Surprises

Earnings surprises can significantly impact Sellas Life's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2024-11-07
2024-09-30-0.1267-0.10.026721 
2024-08-13
2024-06-30-0.16-0.130.0318 
2023-08-10
2023-06-30-0.35-0.310.0411 
2024-05-14
2024-03-31-0.16-0.21-0.0531 
2022-11-14
2022-09-30-0.39-0.340.0512 
2022-08-11
2022-06-30-0.35-0.41-0.0617 
View All Earnings Estimates

Sellas Life Stock Latest Headlines

Some academic researchers believe in a strong correlation between financial news and their impacts on the movements of stock prices. Macroaxis does not take a position on this subject and only provides tools that can help investors to time the market using conventional financial analysis. Below is the latest headlines and news related to Sellas Life Sciences Stock. Current markets are slightly bullish. About 58% of major world exchanges and indexes are currently up. See today's market update for more information.
Yahoo News
21st of November 2024
Sims Lifecycle Services Listed as a Representative Vendor in the 2024 Gartner Market Guide...
at finance.yahoo.com 
seekingalpha News
13th of November 2024
SELLAS Life Sciences GAAP EPS of -0.10 beats by 0.03
at seekingalpha.com 
Yahoo News
5th of November 2024
SELLAS Life Sciences to Present at the 66th American Society of Hematology Annual Meeting ...
at finance.yahoo.com 
Yahoo News
15th of October 2024
SELLAS Announces U.S. FDA Rare Pediatric Disease Designation Granted to Galinpepimut-S for...
at finance.yahoo.com 
Yahoo News
14th of October 2024
Monster Energys Giovanni Vianna Takes Second Place in Mens Skateboard Street Liz Akama Cla...
at finance.yahoo.com 
Yahoo News
10th of October 2024
SELLAS Life Sciences to Participate in Fireside Chat at the 2024 Maxim Healthcare Virtual ...
at finance.yahoo.com 
Yahoo News
7th of October 2024
Solaris Reports 87m of 1.23 percent CuEq, 93m of 1.01 percent CuEq and 84m of 1.00 percent...
at finance.yahoo.com 
insidermonkey News
18th of September 2024
Sellas Life Sciences Group Inc A Bull Case Theory
at insidermonkey.com 
Yahoo News
5th of September 2024
Sodium Lauryl Sulfate Market is Projected to Grow at a 5.1 percent CAGR, Expected to Hit U...
at finance.yahoo.com 

Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Sellas Life in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Sellas Life's short interest history, or implied volatility extrapolated from Sellas Life options trading.

Additional Tools for Sellas Stock Analysis

When running Sellas Life's price analysis, check to measure Sellas Life's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sellas Life is operating at the current time. Most of Sellas Life's value examination focuses on studying past and present price action to predict the probability of Sellas Life's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sellas Life's price. Additionally, you may evaluate how the addition of Sellas Life to your portfolios can decrease your overall portfolio volatility.